Latent tuberculosis infection and kidney transplantation.
作者信息
Tuon Felipe Francisco
机构信息
Pontifícia Universidade Católica do Paraná, Faculdade de Medicina, Laboratório de Doenças Infecciosas Emergentes, Curitiba, PR, Brasil.
出版信息
J Bras Nefrol. 2021 Oct-Dec;43(4):455-456. doi: 10.1590/2175-8239-JBN-2021-E008.
Abstract
摘要
相似文献
1
Latent tuberculosis infection and kidney transplantation.
J Bras Nefrol. 2021 Oct-Dec;43(4):455-456. doi: 10.1590/2175-8239-JBN-2021-E008.
2
Re: Interferon-gamma release assay agreement with tuberculin skin test in pretransplant screening for latent tuberculosis in a high-prevalence country.
Iran J Kidney Dis. 2014 Sep;8(5):432-3.
3
Latent Tuberculosis Infection Increases in Kidney Transplantation Recipients Compared With Transplantation Candidates: A Neglected Perspective in Tuberculosis Control.
Clin Infect Dis. 2020 Aug 14;71(4):914-923. doi: 10.1093/cid/ciz851.
4
Diagnostic potential of interferon-gamma release assay to detect latent tuberculosis infection in kidney transplant recipients.
Transpl Infect Dis. 2017 Apr;19(2). doi: 10.1111/tid.12675. Epub 2017 Mar 16.
5
[Advances in the diagnosis of latent tuberculosis infection in patients receiving renal replacement therapy].
Nefrologia. 2011;31(2):137-41. doi: 10.3265/Nefrologia.pre2011.Feb.10823.
6
Poor predictability of QuantiFERON-TB assay in recipients and donors for tuberculosis development after kidney transplantation in an intermediate-TB-burden country.
BMC Nephrol. 2017 Mar 14;18(1):88. doi: 10.1186/s12882-017-0506-9.
7
Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation.
Liver Transpl. 2013 Apr;19(4):457-61. doi: 10.1002/lt.23622. Epub 2013 Mar 22.
8
Treatment of latent tuberculosis infection with short-course regimens in potential living kidney donors.
Transpl Infect Dis. 2020 Apr;22(2):e13244. doi: 10.1111/tid.13244. Epub 2020 Jan 21.
9
Diagnostic usefulness of a T cell-based assay for latent tuberculosis infection in kidney transplant candidates before transplantation.
Transpl Infect Dis. 2010 Apr;12(2):113-9. doi: 10.1111/j.1399-3062.2010.00495.x. Epub 2010 Jan 25.
10
[The clinical application of quantiferon TB-2G: its usefulness and limitations].
Kekkaku. 2011 Feb;86(2):101-12.
本文引用的文献
1
Risk factors and clinical outcomes of tuberculosis among kidney transplant recipients in high endemic country.
Transpl Infect Dis. 2021 Jun;23(3):e13566. doi: 10.1111/tid.13566. Epub 2021 Jan 25.
2
Latent Tuberculosis Infection Increases in Kidney Transplantation Recipients Compared With Transplantation Candidates: A Neglected Perspective in Tuberculosis Control.
Clin Infect Dis. 2020 Aug 14;71(4):914-923. doi: 10.1093/cid/ciz851.
3
The usefulness of quantitative interferon-gamma releasing assay response for predicting active tuberculosis in kidney transplant recipients: A quasi-experimental study.
J Infect. 2020 Sep;81(3):403-410. doi: 10.1016/j.jinf.2020.06.070. Epub 2020 Jun 29.
4
Tests for latent tuberculosis in candidates for solid organ transplantation: A systematic review and meta-analysis.
Clin Transplant. 2019 Aug;33(8):e13643. doi: 10.1111/ctr.13643. Epub 2019 Jul 6.
5
Positivity rate of interferon-γ release assays for estimating the prevalence of latent tuberculosis infection in renal transplant recipients in Japan.
J Infect Chemother. 2019 Jul;25(7):537-542. doi: 10.1016/j.jiac.2019.02.018. Epub 2019 Mar 21.
6
Prevalence of latent Mycobacterium tuberculosis infection in renal transplant recipients.
J Bras Pneumol. 2018 Nov-Dec;44(6):461-468. doi: 10.1590/S1806-37562017000000367.
7
Interferon-gamma release assay for tuberculosis screening of solid-organ transplant recipients is cost-effective.
J Infect. 2019 Jan;78(1):58-65. doi: 10.1016/j.jinf.2018.07.003. Epub 2018 Jul 24.
8
Diagnostic potential of interferon-gamma release assay to detect latent tuberculosis infection in kidney transplant recipients.
Transpl Infect Dis. 2017 Apr;19(2). doi: 10.1111/tid.12675. Epub 2017 Mar 16.
9
Serial testing for latent tuberculosis infection in transplant candidates: a retrospective review.
Transpl Infect Dis. 2016 Feb;18(1):14-21. doi: 10.1111/tid.12489. Epub 2016 Feb 3.
10
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.
Eur Respir J. 2015 Dec;46(6):1563-76. doi: 10.1183/13993003.01245-2015. Epub 2015 Sep 24.
Zotero 插件